DJIA 17,712.66 34.43 0.19%
NASDAQ 4,891.22 27.86 0.57%
S&P 500 2,061.02 4.87 0.24%
market minute promo

Prothena Corporation (NASDAQ: PRTA)

37.84 1.28 (3.50%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

PRTA $37.84 3.50%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $36.41
Previous Close $36.56
Daily Range $36.14 - $38.36
52-Week Range $16.71 - $45.00
Market Cap $1.0B
P/E Ratio -126.07
Dividend (Yield) $0.00 (0.0%)
Volume 385,231
Average Daily Volume 635,868
Current FY EPS -$2.49



Prothena Corporation (PRTA) Description

Prothena Corporation plc - Ordinary Shares Website:

News & Commentary

3 Little-Known Biotechs Working On Potential Blockbusters

These three biotechs have promising drugs in their pipelines that address billion dollar drug markets.

The Zacks Analyst Blog Highlights: Biogen, Prothena, Vertex, Gilead and Amgen - Press Releases

This Tiny Biotech Offers Up New Hope for Parkinson's Disease Patients

Phase 1 trial results for Prothena Corporation's PRX-002 could indicate that this drug may help treat Parkinson's disease someday.

How Big Will The Biotech Bubble Get?

Prothena (PRTA) Is Today's Perilous Reversal Stock

Jim Cramer's Top Takeaways: Papa Murphy's, Nike, Prothena

Prothena's PRX002 Positive in Parkinson's Disease Study - Analyst Blog

What's Going On With Prothena Corporation?

Prothena (PRTA) Potential Parkinson's Treatment, Envivio (ENVI) Improved Results, Nike (NKE) ...

Cramer -- 'It's OK to Be Careful' With Biotech Stocks After Big Rally

See More PRTA News...